CARL — CARLSMED, INC.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1794546 ·
Last close
$15.80
Market Cap
$431.38M
52W High
$17.23
52W Low
$9.48
ADV30
160,772
Next earnings
2026-11-05
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 18,940,000 14,542,000 -11,036,000 -10,510,000 118,202,000 46,244,000 33,956,000
Mar 2026 16,116,000 12,425,000 -9,276,000 -8,696,000 118,769,000 73,016,000 26,521,000
Dec 2025 15,165,000 11,608,000 -9,318,000 -8,613,000 130,120,000 85,793,000 31,251,000
Sep 2025 13,074,000 9,927,000 -9,035,000 -8,526,000 134,863,000 115,373,000 28,203,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-34,145,000
Investing CF
$-44,436,000
Financing CF
$91,353,000
CapEx
$-1,528,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.43
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-120,028,000
Inventory
$2,275,000
Receivables
$13,775,000
ST Investments
$42,980,000
EBIT TTM
$-35,011,000
Pretax Income TTM
$-36,345,000
Interest Exp TTM
$1,334,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$63,295,000
EBITDA
$-38,256,000
Free Cash Flow
$-26,408,376
Enterprise Value
$364,076,352
Total Cash
$89,224,000
Total Debt
$21,917,000
Shares Out
27,302,743
Trailing EPS
$-2.30
Book Value
$3.09
ROE
-66.1%
ROA
-28.2%
Div Yield

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 50,511,000 -30,574,000 -29,634,000 130,120,000 31,251,000 -28,977,000
Dec 2024 27,165,000 -24,122,000 -24,257,000 51,824,000 122,454,000 -25,466,000
Dec 2023 13,778,000 -18,591,000 -18,898,000 14,024,000 60,154,000 -17,480,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-1.38

Peers — same industry

TickerNameMarket CapLastDaily %
SGHT Sight Sciences, Inc. $461.64M $8.38
SI SHOULDER INNOVATIONS, INC. $462.60M $22.22
CLPT ClearPoint Neuro, Inc. $462.75M $15.17
OFIX Orthofix Medical Inc. $398.77M $9.79
NPCE NeuroPace Inc $480.20M $13.99

News headlines (Yahoo Finance, 1h cache)

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform
2026-08-13 01:04 · Yahoo
Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ...
2026-08-06 05:05 · Yahoo
Carlsmed Q2 Earnings Call Highlights
2026-08-06 00:04 · Yahoo
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates
2026-08-05 22:10 · Yahoo
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
2026-08-03 12:00 · Yahoo
Will Carlsmed, Inc. (CARL) Report Negative Earnings Next Week? What You Should Know
2026-07-29 14:00 · Yahoo
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
2026-07-27 20:01 · Yahoo
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 20:01 · Yahoo
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
2026-05-25 13:55 · Yahoo
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet
2026-05-08 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.